247 related articles for article (PubMed ID: 17135005)
1. Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Shin SW; Han H; Choo SW; Yoo BC; Park CK; Do YS; Lee JH; Lee DH; Choi D; Choo IW; Kim SS; Lee JY
Acta Radiol; 2006 Dec; 47(10):1036-41. PubMed ID: 17135005
[TBL] [Abstract][Full Text] [Related]
2. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
[TBL] [Abstract][Full Text] [Related]
3. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.
Chang JM; Chung JW; Jae HJ; Eh H; Son KR; Lee KC; Park JH
Acad Radiol; 2007 Jan; 14(1):85-92. PubMed ID: 17178370
[TBL] [Abstract][Full Text] [Related]
4. [Effects of intra-arterial infusion of 3-bromopyruvate on metastases and survival benefit of hepatic VX2 tumor in rabbits].
Jiang XY; Zhang XP; Huang JH; Luo RG; Miao BJ; Wang Y
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(39):3139-42. PubMed ID: 24417996
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
Park HS; Chung JW; Jae HJ; Kim YI; Son KR; Lee MJ; Park JH; Kang WJ; Yoon JH; Chung H; Lee K
Korean J Radiol; 2007; 8(3):216-24. PubMed ID: 17554189
[TBL] [Abstract][Full Text] [Related]
7. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Jae HJ; Chung JW; Park HS; Lee MJ; Lee KC; Kim HC; Yoon JH; Chung H; Park JH
Korean J Radiol; 2009; 10(6):596-603. PubMed ID: 19885316
[TBL] [Abstract][Full Text] [Related]
8. Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method.
Lin WY; Tsai SC; Hsieh JF; Wang SJ
J Nucl Med; 2000 Nov; 41(11):1892-7. PubMed ID: 11079501
[TBL] [Abstract][Full Text] [Related]
9. [Adriamycin thermotherapy through hepatic artery for model of VX2 carcinoma in rabbit liver].
Zhang HX; Liu Y; Cao W; Wang ZM; Guo WP; Ni DH; Liu YY; Wang YQ; Li WX; Fan AL; Han RY
Ai Zheng; 2002 Aug; 21(8):843-5. PubMed ID: 12478889
[TBL] [Abstract][Full Text] [Related]
10. The effect of benzamide riboside on the VX2 model of liver cancer in rabbits.
McLennan G; Cressman EN; Xu Y; Zhang D; Jagtap MR; Jayaram HN
J Vasc Interv Radiol; 2005 Nov; 16(11):1499-504. PubMed ID: 16319157
[TBL] [Abstract][Full Text] [Related]
11. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Geschwind JF; Ko YH; Torbenson MS; Magee C; Pedersen PL
Cancer Res; 2002 Jul; 62(14):3909-13. PubMed ID: 12124317
[TBL] [Abstract][Full Text] [Related]
12. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
Vali M; Vossen JA; Buijs M; Engles JM; Liapi E; Ventura VP; Khwaja A; Acha-Ngwodo O; Ganapathy-Kanniappan S; Syed L; Wahl RL; Geschwind JF
J Pharmacol Exp Ther; 2008 Oct; 327(1):32-7. PubMed ID: 18591216
[TBL] [Abstract][Full Text] [Related]
13. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Vossen JA; Buijs M; Syed L; Kutiyanwala F; Kutiyanwala M; Geschwind JF; Vali M
Clin Exp Metastasis; 2008; 25(7):811-7. PubMed ID: 18649116
[TBL] [Abstract][Full Text] [Related]
14. Effect of transarterial pulsed perfusion with heated saline on tumor vascular permeability in a rabbit VX2 liver tumor model.
Cao W; Li JH; Feng DY; Wan Y; Liu YF; Yang QF; Cheng JW; Zhao SY; Zhang HX
Eur J Radiol; 2012 Mar; 81(3):e209-16. PubMed ID: 21345630
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study on the comparative efficacy of hepatic arterial or portal venous infusion of adriamycin to control hepatic carcinoma growth].
Hoshino M; Koyama Y; Abe R
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1894-7. PubMed ID: 1877833
[TBL] [Abstract][Full Text] [Related]
16. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection.
Kaneko A; Naomoto Y; Aoyama M; Tanaka N
In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the efficacy of hepatic arterial and portal venous infusion of adriamycin for prevention of liver metastases in rabbit VX2].
Koyama Y; Hoshino M; Igarashi W; Ono T; Hatakeyama Y; Abe R
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1540-3. PubMed ID: 1530303
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres for use in chemoembolization of VX2 liver tumors.
Maeda N; Osuga K; Shimazu K; Morii E; Mikami K; Hori S; Nakazawa T; Higashihara H; Tomoda K; Nakamura H; Tomiyama N
J Vasc Interv Radiol; 2012 Mar; 23(3):397-404.e1. PubMed ID: 22209264
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver.
Izumi B; Tashiro S; Miyauchi Y
Cancer Res; 1986 Aug; 46(8):4167-70. PubMed ID: 3089588
[TBL] [Abstract][Full Text] [Related]
20. Destruction of VX2 tumor in rabbits by hyperthermia plus bleomycin suspended in sesame oil.
Kitamura M; Sugimachi K; Maekawa S; Kai H; Kuwano H; Matsuda H
Cancer Treat Rep; 1986 Nov; 70(11):1263-9. PubMed ID: 2429762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
